It is now well-appreciated that post-translational modifications (PTMs) play an integral role in regulating a protein's structure and function, which may be essential for a given protein's role both physiologically and pathologically. Enrichment of PTMs is often necessary when investigating the PTM status of a target protein, because PTMs are often transient and relatively low in abundance. Many pitfalls are encountered when enriching for a PTM of a target protein, such as buffer incompatibility, the target protein antibody is not IP-compatible, loss of PTM signal, and others. The degree of difficulty is magnified when investigating multiple PTMs like acetylation, ubiquitination, SUMOylation 2/3, and tyrosine phosphorylation for a given target protein. Studying a combination of these PTMs may be necessary, as crosstalk between PTMs is prevalent and critical for protein regulation. Often, these PTMs are studied in different lysis buffers and with unique inhibitor compositions. To simplify the process, a unique denaturing lysis system was developed that effectively isolates and preserves these four PTMs; thus, enabling investigation of potential crosstalk in a single lysis system. A unique filter system was engineered to remove contaminating genomic DNA from the lysate, which is a problematic by-product of denaturing buffers. Robust affinity matrices targeting each of the four PTMs were developed in concert with the buffer system to maximize the enrichment and detection of the endogenous states of these four PTMs. This comprehensive PTM detection toolset streamlines the process of obtaining critical information about whether a protein is modified by one or more of these PTMs.
Introduction
Post-translational modifications (PTMs) are highly regulated alterations to a protein, whereby the modification is added or removed in a specific manner. PTMs are often dynamic, transient changes that significantly alter the protein's structure, interactions with partner proteins, and spatial localization, and ultimately enabling the protein to perform distinct functions 1, 2, 3, 4 . PTMs are so abundant that they increase the number of unique protein forms (or proteoforms) from about 30,000 gene products to over a million proteoforms 5, 6 . Identifying PTMs and defining their effect on a target protein is critical towards understanding the protein's physiological and pathological functions 7, 8, 9, 10, 11, 12, 13, 14 . Work on select proteins like tubulin, p53, and epidermal growth factor receptor (EGFR) have elucidated the regulatory roles of PTMs 15, 16, 17 . These studies uncovered the fact that regulation of these proteins occurs by multiple PTMs, and in many cases these modifications work in concert to promote a specific function. New studies have shown that both cooperative and negative PTM crosstalk can occur on several different proteins 18, 19, 20, 21, 22, 23, 24, 25 . However, the PTM profiles of the majority of proteins are built from several studies that have used different models and unique conditions. Having an optimized system to investigate multiple PTMs in one system would be highly beneficial to gain insight into potential PTM crosstalk for a target protein.
One challenge with investigating PTMs in a single system is that specific PTMs are investigated using distinct lysis buffers. For example, the utilization of buffers like RIPA or NP-40 that are commonly used for phosphorylation or ubiquitination investigations may be inadequate for studying a labile PTM like small ubiquitin-like modifier (SUMO)ylation 26 . Additionally, non-denaturing buffers are inadequate for dissociating protein interactions, and can lead to false positive PTM identification 27 . Investigating PTMs in a denaturing lysis buffer may be preferred, as it is significantly better at isolating proteins from all cellular compartments 28 , will dissociate most protein interactions, and will inhibit proteases that alter PTM states, such as deSUMOylases 26 ; however, denaturing buffers may compromise the integrity of specific affinity reagents such as ubiquitin binding domain-based tools 27 . Developing a denaturing-like lysis system to study multiple PTMs of a protein in an affinity reagentcompatible system would be highly beneficial for PTM crosstalk investigations.
9. Based on protein concentration, dilute sample with a buffer mix (1 part blastR lysis: 4 parts blastR dilution) to a desired final concentration (usually 1 mg/mL). 10. Snap freeze aliquots of samples that will not be used immediately.
1. Store samples at -70 °C.
2. Proceed to Section 3.
Immunoprecipitation (IP) Assay
NOTE: Affinity bead concentrations, lysate concentrations, and incubation times are recommended guidelines, and may be unique for each target protein and specific PTM being investigated.
1. Invert stock reagent tubes containing Ub affinity beads, pY affinity beads, SUMO 2/3 affinity beads, and Ac affinity beads several times to make sure that the beads are completely resuspended in the tube. 2. For each IP assay, aliquot bead suspension into separate 1.5 mL microcentrifuge tubes on ice (IP tube). Here, add 20 µL of ubiquitin affinity beads, 30 µL of phosphotyrosine affinity beads, 40 µL of SUMOylation 2/3 affinity beads, or 50 µL of acetylation affinity beads to individual 1.5 mL microcentrifuge tubes on ice. NOTE: See Table 4 for the recommended volume of bead suspension to use for each affinity bead. 3. Invert stock reagent tubes containing ubiquitination IP control beads and IgG control beads several times to make sure that the beads are completely resuspended in the tube. 4. Aliquot control beads per control reaction to determine non-specific binding (Control IP tube). Here, add 20 µL of Ub control beads, 30 µL of pY control beads, 40 µL of SUMO 2/3 control beads, or 50 µL of Ac control beads to individual 1.5 mL microcentrifuge tubes on ice. NOTE: See Table 4 for the recommended volume of bead suspension to use for each type of affinity bead. 5. Save a small amount of lysate (20 µL) to run as a western blot input lysate control. Add 5 µL of 5x sample buffer and boil at 95 °C for 5 min.
NOTE: See Table of Materials for buffer composition. 6. Add lysate to each IP tube and control IP tube. Here, 1 mg of lysate was used per IP and control reaction, resulting in a total of 8 IP reactions.
NOTE: 1.0 mg of lysate per assay is recommended as a starting point. The amount of lysate required will vary depending upon the abundance of modified target protein. 7. Incubate the tubes on an end-over-end rotating platform at 4 °C for 2 h. Here, an ATR tube rotator was used at speed 22. 8. Collect beads by centrifugation at 3,000 -5,000 x g for 1 min at 4 °C. 9. Aspirate off as much supernatant as possible without disturbing the beads. 10. Wash beads in 1 mL blastR Wash Buffer (inhibitors are not necessary at this stage) for 5 min on a 4 °C rotating platform. 11. Collect beads by centrifugation at 3,000 -5,000 x g for 1 min at 4 °C. 12. Aspirate off as much supernatant as possible without disturbing the beads. 13. Repeat the wash step (steps 3.10 -3.12) two more times. 14. After the final wash, completely remove buffer supernatant. Minimal disruption of the bead pellet is acceptable (up to a 5% loss). Remove residual supernatant using a fine bore protein loading tip. 15. Add 30 µL of bead elution buffer, and resuspend the beads by gently tapping/flicking the side of the tube. DO NOT use a pipette at this stage.
NOTE: See Table of Materials for buffer composition. 16. Incubate at room temperature for 5 min. 17. Gently transfer each bead suspension to a 1.5 mL microcentrifuge spin column that has been placed in a 1.5 mL microcentrifuge tube. NOTE: It is recommended to snip the end off of the transfer pipette tip for gentler transfer. 18. Centrifuge at 9,000 -10,000 x g for 1 min at room temperature to collect the IP sample. 19. Add 2 µL of 2-mercaptoethanol to each sample and mix well. NOTE: It is convenient to snap the lid off the spin column and use this to cap the collection tube for further processing. 20. Place samples in a 95 °C water bath for 5 min. Collect sample by centrifugation at 10,000 x g for 1 min at RT. 21. If necessary, store samples at -70 °C and stop here, or proceed to running SDS-PAGE, transfer, and western blot analysis (Section 4). NOTE: The chemiluminescent reagent should be used in conjunction with an HRP-labeled secondary antibody capable of detecting the primary antibody. 4. Use a volume of 2 mL of chemiluminescent reagent per mini-gel-sized transfer membrane (approximately 8 x 7 cm).
Western Blot Analysis: Identification of Protein of Interest
1. After incubation with appropriate secondary antibody (60 min at RT is recommended), wash the blot 6 x 10 min in 30 mL of tris-buffered saline with tween-20 (TBST). NOTE: See Table of Materials for buffer composition. 2. Immediately before use, mix 1 mL of chemiluminescent reagent A with 1 mL of chemiluminescent reagent B (sufficient for one 8 cm x 7 cm membrane). 3. Add chemiluminescent reagent to membrane and incubate with gentle rocking at RT for 1 -5 min prior to visualization of protein signal using x-ray film or charge-coupled device (CCD) camera imaging. NOTE: Shorter incubation times in the chemiluminescent reagent may be necessary for highly abundant proteins. Serum-restricted A431 cells were either unstimulated (UT) or stimulated with EGF for one hour prior to lysis with BlastR lysis buffer. WCL was analyzed for PD-L1 levels (lanes 1,2). Ubiquitin binding beads (UBA01) were used to IP ubiquitinated proteins (lanes 3,4). Phosphotyrosine binding beads (APY03) were used to IP tyrosine-phosphorylated proteins (lanes 5,6). SUMO 2/3 binding beads (ASM24) were used to IP SUMOylated 2/3 proteins (lanes 7,8). Acetyl lysine binding beads (AAC01) were used to IP acetylated proteins (lanes 9,10). IgG binding control beads were used to IP non-specific binding proteins (lanes 11,12). Samples were separated by SDS-PAGE and analyzed by western blot using a PD-L1 antibody. A representative blot from N ≥3 independent experiments is shown. White asterisks were used to highlight PD-L1 pY and Ac protein bands. Please click here to view a larger version of this figure.
Calculations for BlastR lysis buffer 
Discussion
Initial approaches used to determine if a target protein is modified by a PTM can be performed using the target protein specific antibody for IP, followed by western blot with a PTM antibody (e.g., anti-acetyl lysine), or by using a PTM antibody for IP, followed by western blot with the target protein specific antibody 30, 31, 33 . While both approaches theoretically work, utilizing a target-protein-specific antibody has more potential pitfalls, such as the antibody may not be IP compatible, or large PTM modifications may block the antibody recognition site on the target protein 34, 35 . The advantage of the PTM affinity beads is that the antibody or binding domains specifically recognize the PTM of interest; thus, modifications to the target protein should not alter recognition by the affinity beads. As an example, PD-L1 Ub was identified with the technique described here, and both endogenous mono-and poly-Ub was observed (Figure 4) . A recent publication by Lim et al. utilized in vitro Ub techniques to investigate PD-L1 Ub, and the result was very similar to the results shown in Figure 4 
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. Interestingly, they also performed IP with a PD-L1 antibody to enrich PD-L1 from cell lysate, where Ub was overexpressed and MG-132 was added to enhance the signal. The Ub pattern was not robust and very distinct from the in vitro Ub pattern. Investigation of endogenous PD-L1 Ub in cell culture models was not performed in the Lim et al. report to clarify the difference between their cell culture and in vitro data.
Investigating whether a protein is modified by a PTM can be challenging, due to its low abundance and transient nature 37, 38 , and often requires enrichment through IP. Effective IP of PTMs requires optimization of several key steps and reagents, such as lysis buffers and affinity reagents. When investigating multiple PTMs of a target protein, the required optimization likely increases. Utilizing the blastR lysis system is a critical step in this protocol, as it maintains robust IP capability, while enabling PTM detection of the pY, SUMO 2/3, Ub, and Ac PTMs in a single system. This technique optimizes the time and resources required to determine if a specific target protein is modified by these four PTMs, and potentially provides a better picture of PTM crosstalk relative to comparing PTM results performed using multiple lysis systems. Investigation of the blastR lysis system's compatibility with alternative PTMs, like glycosylation, was performed; however, it has not been examined exhaustively for all types of PTMs.
Copious genomic DNA can interfere with protein measurements using either colorimetric or nanodrop methods, affect the migration of proteins in an SDS acrylamide gel, and prevent protein and affinity matrix interaction during IP assays. The method described here utilizes a specialized filter to effectively remove genomic DNA contamination, which is another critical step of this protocol. To highlight this point, viscosity tests were performed before and after blastR filter treatment, and the results showed a reduction from a high viscosity to the viscosity of water (data not . Utilizing the filter takes 5 -30 seconds per sample compared to alternative methods where effective breakdown of DNA may take several minutes (i.e., syringe shearing) and can result in sample heterogeneity as DNA contaminants remain in the lysate. Extensive analysis of the lysate pre-and postblastR filtering was performed, and no observable difference in the protein profile was observed by Coomassie, target-specific western, or total and target-specific PTM analyses; thus, the integrity of the protein profile may not have been affected by filtering out the genomic DNA. Ultimately, this filter system is beneficial for any western or IP application where genomic DNA is present and may affect interpretation of the protein analysis.
It is important to note that there is potential for false negative detection utilizing this technique, which may be due in part to affinity bead saturation, binding site interference, or PTM masking. For instance, a particular target protein may be modified by Ac at very low levels; thus, it may not be isolated by pan-acetyl lysine affinity beads that have been saturated by more abundant Ac-modified target proteins. Ongoing studies are being performed to assess the detection limits of the affinity reagents utilized in this protocol, but a recent publication suggests a very robust detection limit. The data showed that this technique could identify as few as 17 acetylated target protein molecules per cell 31 . Still, specific circumstances such as cell type specificity, transient PTMs in response to specific stimuli, or masking of PTMs due to protein interaction may all result in false negative results. These are potential pitfalls of this technique, as well as most PTM IP methods. Thus, it is recommended to confirm results using multiple approaches.
Modifications like glycosylation and phosphorylation have been shown to compete for similar amino acids 39, 40 , and other PTMs like ubiquitination and phosphorylation have been shown to work sequentially to regulate a protein's function 17, 41 . Recent work on the neuropathological protein Tau highlighted the importance of PTM crosstalk, where Tau hyper-phosphorylation and Tau SUMOylation enhanced each other 42 . Moreover, this group showed that SUMOylation of Tau prevented poly-Ub and subsequent Tau degradation, possibly leading to aggregation. This is just one of many examples of regulatory PTM crosstalk, and the utility of this technique will help to illuminate the importance of PTMs and their crosstalk in regulating key proteins in health and disease. 
